GLAXF News and Press, GlaxoSmithKline Plc From 07/21/23

2023-07-21 11:08:50 ET Summary On July 27, 2023, Bristol-Myers Squibb, one of the leaders in the global cancer and immunology therapeutics market, will release its financial report for the second quarter of 2023. In the first half of 2023, the company delighted investors with nume...

2023-07-13 05:33:31 ET Summary Some legal headwinds from previous coverage have abated. GSK's usage estimate for Arexvy this year is likely on the low side. Two upcoming Prescription Drug User Fee Act action dates for other treatments occur in September. In previous ...

2023-07-10 23:47:00 ET Summary The UK is apparently teetering on the edge of a recession, the UK’s long-ticking mortgage time-bomb is in the process of exploding and the FTSE 100 has fallen back towards 7,000, where it has spent most of the last 25 years. After falling back...

2023-07-10 07:00:00 ET Summary If a company is going to survive and thrive over many decades, it must focus on what it can do better than its peers. A flywheel may give a company an enduring competitive advantage that widens with each turn of the wheel. Quality dividend stocks...

2023-07-06 18:20:15 ET Summary Moderna, Inc. has submitted multiple regulatory submission of mRNA-1345 as an RSV vaccine in older adults ages 60 and older; additional regulatory submissions expected in coming months. The global respiratory syncytial virus market is expected to rea...

2023-07-05 15:06:02 ET Summary Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreement with GSK. In addition, Spero has two other assets that will soon be evaluated in proof-of-concep...

2023-06-29 05:41:44 ET Summary Haleon is one of the largest consumer healthcare businesses in the world, with leading brands in many of the key segments. We expect a healthy increase in demand going forward, as OTC healthcare products continue to be seen as a required part of an i...

2023-06-13 15:35:20 ET GSK plc (GSK) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 12:20 ET Company Participants Tony Wood - Chief Scientific Officer Conference Call Participants Chris Shibutani - Goldman Sachs Presentation ...

2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...

2023-05-14 06:57:39 ET Summary WisdomTree International Quality Dividend Growth Fund holds global dividend stocks with quality and growth characteristics. It is well-diversified across countries and sectors, but it is quite concentrated in the top holdings. Historical performa...